Transient increase in the risk of breast cancer after giving birth.

Control of mammary stem cell function by steroid hormone signalling. Nature (2010) 5.38

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev (2009) 4.29

The causes and prevention of cancer. Proc Natl Acad Sci U S A (1995) 3.71

How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst (2014) 3.43

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst (2006) 2.25

Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med (2011) 2.12

Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer. Stem Cells (2008) 1.96

Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer (2005) 1.94

BRCA1 functions as a breast stem cell regulator. J Med Genet (2004) 1.92

Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res (2004) 1.85

Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer (2002) 1.77

Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A (1996) 1.70

Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol (2010) 1.65

Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia (2009) 1.55

Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50

Breast Cancer Risk - Genes, Environment and Clinics. Geburtshilfe Frauenheilkd (2011) 1.47

Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat (2002) 1.40

The breast cancer and the environment research centers: transdisciplinary research on the role of the environment in breast cancer etiology. Environ Health Perspect (2009) 1.38

Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer (2008) 1.31

Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat (2013) 1.24

Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol (2005) 1.24

The biology of progesterone receptor in the normal mammary gland and in breast cancer. Mol Cell Endocrinol (2011) 1.19

BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res (2003) 1.17

Reproductive history and breast cancer risk. Breast Cancer (2012) 1.14

Fertility drugs and the risk of breast and gynecologic cancers. Semin Reprod Med (2012) 1.13

Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer (1997) 1.11

Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol (2008) 1.10

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood (2005) 1.09

Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res (2008) 1.07

Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst (2014) 1.06

Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control (2007) 1.05

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2006) 1.03

Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control (2010) 1.01

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis. Geburtshilfe Frauenheilkd (2013) 1.00

Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res (2005) 0.99

Cancer risk in DES daughters. Cancer Causes Control (2010) 0.97

Risk factors for breast cancer in a black population--the Barbados National Cancer Study. Int J Cancer (2009) 0.96

Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat (2014) 0.95

Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer (2010) 0.94

Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res (2012) 0.94

From the ranks of mammary progesterone mediators, RANKL takes the spotlight. Mol Cell Endocrinol (2011) 0.94

Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer (2010) 0.93

Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb. Bioessays (2015) 0.93

Developmental and environmental origins of breast cancer: DDT as a case study. Reprod Toxicol (2010) 0.91

Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer (2013) 0.91

Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study. Breast Cancer Res Treat (2013) 0.90

Breast cancer diagnosis during pregnancy. Womens Health (Lond Engl) (2009) 0.89

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res (2014) 0.88

The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res (2010) 0.87

Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women. Cancer Epidemiol Biomarkers Prev (2012) 0.87

Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study. Hum Reprod (2011) 0.86

Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies. Int J Cancer (2016) 0.86

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Res (2012) 0.85

Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 0.85

Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res (2014) 0.84

Stem cells: Cues from steroid hormones. Nature (2010) 0.83

EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer. Cancer Lett (2005) 0.83

Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Oncogene (2006) 0.83

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control (2010) 0.82

Breast cancer risk after use of fertility drugs: stimulating new controversy. J Natl Cancer Inst (2012) 0.82

Birth weight, breast cancer and the potential mediating hormonal environment. PLoS One (2012) 0.82

Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment. Int J Cancer (2013) 0.81

Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat (2014) 0.81

Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling. Cell Death Dis (2014) 0.81

Differentially expressed microRNAs in postpartum breast cancer in Hispanic women. PLoS One (2015) 0.80

Mammary gland involution as an immunotherapeutic target for postpartum breast cancer. J Mammary Gland Biol Neoplasia (2014) 0.79

Breast cancer in pregnancy: case report. Pan Afr Med J (2010) 0.79

Hyperemesis gravidarum and subsequent breast cancer risk. Br J Cancer (2002) 0.79

Socioeconomic disparities in breast cancer incidence and survival among parous women: findings from a population-based cohort, 1964-2008. BMC Cancer (2015) 0.78

History of gestational diabetes mellitus (GDM) and risk of incident invasive breast cancer among parous women in the Nurses' Health Study II prospective cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.78

Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study. Oncology (2016) 0.78

Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. Springerplus (2015) 0.78

Pregnancy-associated breast cancer and increased risk of pregnancy-associated recurrence: a case report. J Med Case Rep (2012) 0.77

Elevated breast cancer risk among mothers of a population-based series of 2668 children with cancer. Ecancermedicalscience (2008) 0.77

Birth intervals and breast cancer risk. Br J Cancer (2009) 0.77

Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. Ann Epidemiol (2013) 0.76

The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer. World J Surg (2014) 0.76

Multiple births and breast cancer prognosis: a population based study. Eur J Epidemiol (2005) 0.76

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature. Springerplus (2015) 0.76

Pregnancy and breast cancer. Obstet Med (2010) 0.75

Cell Fate Decisions During Breast Cancer Development. J Dev Biol (2016) 0.75

Stem cells, hormones, and mammary cancer. Adv Exp Med Biol (2008) 0.75

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients. Springerplus (2015) 0.75

Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev (2015) 0.75

Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution. Sci Rep (2017) 0.75

The risk of breast cancer after giving birth. N Engl J Med (1995) 0.75

Pregnancy associated breast cancer and pregnancy after breast cancer treatment. J Turk Ger Gynecol Assoc (2011) 0.75

Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk. PLoS One (2017) 0.75

Survivors of breast cancer. N Engl J Med (2001) 0.75

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist (2015) 0.75

Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study. PLoS One (2016) 0.75

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy. Genes Dev (2017) 0.75

Postpartum breast cancer behaves differently. Facts Views Vis Obgyn (2011) 0.75

Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda. Cancer (2015) 0.75

Harvard report on cancer prevention. Causes of human cancer. Reproductive factors. Cancer Causes Control (1996) 0.75

Reproductive and hormonal risk factors of breast cancer: a historical perspective. Int J Womens Health (2017) 0.75

General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50

High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31

Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25

The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21

Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15

Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05

Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80

Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79

Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79

The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77

Diet and overall survival in elderly people. BMJ (1995) 3.73

Stressful life events and Graves' disease. Lancet (1991) 3.63

Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther (2012) 3.57

Sickness in pregnancy and sex of child. Lancet (1999) 3.48

Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48

Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34

Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25

Lung cancer and passive smoking. Int J Cancer (1981) 3.14

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10

Appendectomy and protection against ulcerative colitis. N Engl J Med (2001) 3.06

Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ (1970) 3.04

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04

Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer (1969) 2.93

Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis (2005) 2.93

Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health (2000) 2.92

Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88

Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88

Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer (1990) 2.82

History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81

Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78

Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75

Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69

Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65

Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64

Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64

10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64

Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58

The impact of endoscopists' experience and learning curves and interendoscopist variation on colonoscopy completion rates. Endoscopy (2001) 2.55

Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55

International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52

Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52

The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51

Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51

Infant leukaemia after in utero exposure to radiation from Chernobyl. Nature (1996) 2.47

Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst (1995) 2.44

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43

Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32

Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31

Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30

Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29

Menopause and breast cancer risk. J Natl Cancer Inst (1972) 2.27

Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther (2000) 2.25

European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr (2002) 2.23

Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22

Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med (2008) 2.21

Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control (2000) 2.19

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19

Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18

Re: Lung cancer case-control study of beryllium workers. Sanderson WT, Ward EM, Steenland K, Petersen MR. Am. J. Ind. Med. 2001. 39:133-144. Am J Ind Med (2001) 2.17

Jewish religion and risk of breast cancer. Lancet (1996) 2.14

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14

Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer (1991) 2.14

Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12

High birthweight as a predictor of prostate cancer risk. Epidemiology (1995) 2.12

Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med (2007) 2.12

Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07

Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06

Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06

Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03

Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03